de Carvalho H B, Mesquita F, Massad E, Bueno R C, Lopes G T, Ruiz M A, Burattini M N
NUPAIDS (Núcleo de Pesquisa em AIDS da USP), São Paulo, Brazil.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 May 1;12(1):84-92. doi: 10.1097/00042560-199605010-00012.
To study the prevalence of HIV and infections with related transmission patterns, we interviewed and obtained blood samples from 220 injecting drug users (IDUs), sampled by snowballing, from the city of Santos in the state of São Paulo, Brazil, where the estimated number of IDUs (10,000) comprises approximately 2% of the entire population. Seroprevalence of HIV, hepatitis B and C, syphilis, and HTLV (1 and 2) was assessed and compared with that in 197 blood donors from the same city, matched for age and gender. Risk behavior related to HIV was assessed by a standard questionnaire applied to the IDU sample. Univariate and multivariate analyses of the risk factors were performed. Seroprevalences found were 62% for HIV, 75% for HCV, 75% for HBV, 34% for syphilis, and 25% for HTLV (1 and 2) among IDUs, which compare with 0.0%, 2%, 23%, 12%, and 1% for blood donors, respectively. The risk for parenterally transmitted infections in this IDU community was higher than that for sexually transmitted infections (odds ratio for syphilis, 3.57; hepatitis B, 10.0; and hepatitis C, 100). The results of the mutivariate risk analysis showed that daily rate of ID use >5 times/day (OR = 6.73), not changing behavior to avoid AIDS (OR= 3.28), ID use >15 days/month (OR = 2.72), and ID use in the last 2 months (OR = 2.23) were the risk behaviors significantly associated with HIV infection.
为研究艾滋病毒的流行情况及相关传播模式的感染情况,我们通过滚雪球抽样法,对来自巴西圣保罗州桑托斯市的220名注射吸毒者(IDU)进行了访谈并采集了血样。该市估计有10000名注射吸毒者,约占全市总人口的2%。评估了艾滋病毒、乙型和丙型肝炎、梅毒以及人类嗜T淋巴细胞病毒(1型和2型)的血清阳性率,并与来自同一城市、年龄和性别匹配的197名献血者的血清阳性率进行了比较。通过应用于IDU样本的标准问卷评估与艾滋病毒相关的风险行为。对风险因素进行了单变量和多变量分析。在IDU中,艾滋病毒的血清阳性率为62%,丙型肝炎为75%,乙型肝炎为75%,梅毒为34%,人类嗜T淋巴细胞病毒(1型和2型)为25%,而献血者的相应比例分别为0.0%、2%、23%、12%和1%。该IDU群体中经肠道外传播感染的风险高于性传播感染(梅毒的优势比为3.57;乙型肝炎为10.0;丙型肝炎为100)。多变量风险分析结果显示,每天注射毒品次数>5次/天(OR = 6.73)、未改变行为以避免感染艾滋病(OR = 3.28)、每月注射毒品>15天(OR = 2.72)以及在过去2个月内有注射毒品行为(OR = 2.23)是与艾滋病毒感染显著相关的风险行为。